Search filters

List of works by Francesco Passamonti

A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis

scientific article published on 10 January 2008

A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment).

scientific article published on 14 December 2009

A final note about ibrutinib in relapsed or refractory CLL: Conclusive results from RESONATE sound definitely good!

scientific article published on 07 November 2019

A gain-of-function mutation of JAK2 in myeloproliferative disorders

scientific article (publication date: 28 April 2005)

A long-term time course of colorimetric assessment of the effects of imatinib mesylate on skin pigmentation: a study of five patients

scientific article published on 01 March 2007

A novel germline JAK2 mutation in familial myeloproliferative neoplasms.

scientific article

A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 Inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea

scientific article

A prognostic model to predict survival in 867 World Health Organization-defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment

scientific article published on 26 June 2012

A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications

scientific article published on 15 July 2010

A unified definition of clinical resistance and intolerance to hydroxycarbamide in polycythaemia vera and primary myelofibrosis: results of a European LeukemiaNet (ELN) consensus process

scientific article published on 23 November 2009

Acquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL-mutated myeloproliferative neoplasms

scientific article published on 10 April 2013

Acute myeloid leukemia (AML) having evolved from essential thrombocythemia (ET): distinctive chromosome abnormalities in patients treated with pipobroman or hydroxyurea.

scientific article published in October 2002

Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2.

scientific article published on 4 August 2005

Aspirin in pregnant patients with essential thrombocythemia: a retrospective analysis of 129 pregnancies

scientific article published on 13 November 2009

Assessment of bone marrow involvement in non-Hodgkin's lymphomas: comparison between histology and flow cytometry.

scientific article published in November 2010

Balancing efficacy and safety of JAK inhibitors in myelofibrosis

scientific article published on 04 January 2014

Bayesian models identify specific lymphoproliferative disorders associated with hepatitis C virus infection.

scientific article published on May 2009

Biochemical markers of bone disease in asymptomatic early stage multiple myeloma. A study on their role in identifying high risk patients

scientific article published on 01 April 2001

Blast phase of essential thrombocythemia: A single center study

scientific article

Blood p50 evaluation enhances diagnostic definition of isolated erythrocytosis.

scientific article

Blood tests may predict early primary myelofibrosis in patients presenting with essential thrombocythemia

scientific article published on 11 January 2012

Bone marrow histology in marginal zone B-cell lymphomas: correlation with clinical parameters and flow cytometry in 120 patients

scientific article published on 21 August 2008

Bone marrow microvessel density in chronic myeloproliferative disorders: a study of 115 patients with clinicopathological and molecular correlations

scientific article published on 19 November 2007

CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons

scientific article (publication date: 9 January 2014)

COVID-19 and hairy-cell leukemia: an EPICOVIDEHA survey

scientific article published on 02 May 2022

COVID-19 in Philadelphia-negative myeloproliferative disorders: a GIMEMA survey

scientific article published on 25 August 2020

Calreticulin mutation does not modify the IPSET score for predicting the risk of thrombosis among 1150 patients with essential thrombocythemia.

scientific article published in October 2014

Cerebral venous thrombosis and myeloproliferative neoplasms: Results from two large databases

scientific article published on 29 March 2014

Changes in quality of life and disease-related symptoms in patients with polycythemia vera receiving ruxolitinib or standard therapy

scientific article published on 26 November 2015

Classification of myeloproliferative neoplasms and prognostic factors

scientific article published in January 2012

Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: consensus statements from European LeukemiaNET (ELN) and Internation Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT)

scientific article

Clinical findings and diagnosis in a case of cholangiocellular carcinoma in a horse

scientific article published on 01 September 2008

Clinical predictors of outcome in MPN.

scientific article published on 28 August 2012

Clinical relevance of JAK2 (V617F) mutant allele burden

scientific article published on January 2009

Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes

scientific article

Clinical relevance of murine double minute 2 single nucleotide polymorphisms 309 in familial myeloproliferative neoplasm

scientific article published on 31 October 2011

Clinical significance of neutrophil CD177 mRNA expression in Ph-negative chronic myeloproliferative disorders

scientific article

Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders

scientific article published on 01 October 2003

Clinical, serological and molecular investigations of EHV-1 and EHV-4 in 15 unweaned thoroughbred foals.

scientific article

Combination of rituximab, cyclophosphamide, and vincristine induces complete hematologic remission of splenic marginal zone lymphoma

scientific article published in March 2004

Correlation of the FLIPI score for follicular lymphoma with period of diagnosis and type of treatment

scientific article published on 19 August 2005

Cytoreductive therapy for patients with essential thrombocythemia at high risk of thromboembolic complications. The difficult choice of the optimal drug.

scientific article published in November 2004

DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status

scientific article

Deep sequencing reveals double mutations in cis of MPL exon 10 in myeloproliferative neoplasms.

scientific article

Deferasirox in the management of iron-overload in patients with myelofibrosis: a multicentre study from the Rete Ematologica Lombarda (IRON-M study)

scientific article published on 20 May 2019

Deletions of the transcription factor Ikaros in myeloproliferative neoplasms.

scientific article published on 27 May 2010

Direct-acting Antivirals in Hepatitis C Virus-positive Mantle Cell Lymphomas

scientific article published on 05 November 2020

Direct-acting antivirals in relapsed or refractory hepatitis C virus-associated diffuse large B-cell lymphoma

scientific article published on 28 April 2020

Disease anticipation in familial myeloproliferative neoplasms

scientific article published on 01 September 2008

Disease characteristics and clinical outcome in young adults with essential thrombocythemia versus early/prefibrotic primary myelofibrosis.

scientific article

Distinct clustering of symptomatic burden among myeloproliferative neoplasm patients: retrospective assessment in 1470 patients

scientific article

Dynamic International Prognostic Scoring System (DIPSS) predicts progression to acute myeloid leukemia in primary myelofibrosis

scientific article

Dyspnea secondary to pulmonary hematopoiesis as presenting symptom of myelofibrosis with myeloid metaplasia.

scientific article published in February 2006

Efficacy of a combination of idarubicin, etoposide and intermediate-dose cytosine arabinoside as salvage therapy in relapsing or resistant unfavorable lymphoma.

scientific article

Efficacy of ruxolitinib in chronic eosinophilic leukemia associated with a PCM1-JAK2 fusion gene

scientific article published on 29 April 2013

Epidemiology and clinical relevance of mutations in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 359 patients of the AGIMM group

scientific article published on 2 April 2016

Essential thrombocythemia and pregnancy: Observations from recent studies and management recommendations

scientific article published in October 2009

European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis. Haematologica 2012;97(3):360-5--comment

scientific article published on March 2012

Everolimus in diffuse large B-cell lymphomas

scientific article

Exaggerated insect bite-like reaction in patients affected by oncohaematological diseases.

scientific article published in January 2005

Familial Chronic Myeloproliferative Disorders: Clinical Phenotype and Evidence of Disease Anticipation

scientific article published on 12 November 2007

Fedratinib in patients with myelofibrosis previously treated with ruxolitinib: An updated analysis of the JAKARTA2 study using stringent criteria for ruxolitinib failure

scientific article published on 04 March 2020

Flow-FISH evaluation of telomere length in Philadelphia-negative myeloproliferative neoplasms.

scientific article published on August 2011

Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression

scientific article published on 29 April 2011

Germline RBBP6 mutations in familial myeloproliferative neoplasms.

scientific article published on 16 November 2015

HLA typing and VH gene rearrangement analysis in a family with hairy cell leukaemia

scientific article published on 01 April 2007

Health-related quality of life and symptoms in patients with myelofibrosis treated with ruxolitinib versus best available therapy

scientific article published on 14 May 2013

High-resolution genome-wide array comparative genomic hybridization in splenic marginal zone B-cell lymphoma

scientific article published on 03 August 2009

How I treat polycythemia vera

scientific article published on 18 May 2012

How the coronavirus pandemic has affected the clinical management of Philadelphia-negative chronic myeloproliferative neoplasms in Italy-a GIMEMA MPN WP survey

scientific article published on 03 July 2020

How to manage polycythemia vera.

scientific article

Identification of genomic aberrations associated with disease transformation by means of high-resolution SNP array analysis in patients with myeloproliferative neoplasm

scientific article published on 22 September 2011

Identifying and addressing unmet clinical needs in Ph-neg classical myeloproliferative neoplasms: a consensus-based SIE, SIES, GITMO position paper

scientific article published on 19 September 2013

Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma

scientific article

Immunochemotherapy with rituximab, vincristine and 5-day cyclophosphamide for heavily pretreated follicular lymphoma.

scientific article published on 4 July 2005

Impact of allogeneic stem cell transplantation on survival of patients less than 65 years of age with primary myelofibrosis.

scientific article published on 17 March 2015

Impact of bone marrow fibrosis grade in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: A study of the MYSEC group

scientific article published on 01 November 2019

Impact of ruxolitinib on the natural history of primary myelofibrosis: a comparison of the DIPSS and the COMFORT-2 cohorts

scientific article

Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomas

article

Improving survival trends in primary myelofibrosis: an international study

scientific article published on 23 July 2012

In contemporary patients with polycythemia vera, rates of thrombosis and risk factors delineate a new clinical epidemiology

scientific article published on 01 November 2014

Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria.

scientific article published on 16 September 2011

Incidence of leukaemia in patients with primary myelofibrosis and RBC-transfusion-dependence.

scientific article published in September 2010

Increase in leukocyte count over time predicts thrombosis in patients with low-risk essential thrombocythemia

scientific article published on 27 June 2009

Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients.

scientific article published on 25 November 2010

Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation

scientific article (publication date: 15 July 2007)

Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome.

scientific article

Investigational therapies targeting lymphocyte antigens for the treatment of non-Hodgkin's lymphoma

scientific article published on 21 April 2015

It is time to change thrombosis risk assessment for PV and ET?

scientific article published on June 2014

Italian survey on clinical practice in myeloproliferative neoplasms. A GIMEMA Myeloproliferative Neoplasms Working Party initiative

scientific article published on 22 June 2019

JAK inhibitor in CALR-mutant myelofibrosis

scientific article published on 01 March 2014

JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations ⬇️

scientific article published on November 16, 2010

JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders

scientific article published in November 2006

JAK2 (V617F) mutation in healthy individuals

scientific article published on 01 February 2007

Leukemia risk models in primary myelofibrosis: an International Working Group study

scientific article published on 13 January 2012

Leukemic transformation of polycythemia vera: a single center study of 23 patients

scientific article published in September 2005

Leukocytosis as an important risk factor for arterial thrombosis in WHO-defined early/prefibrotic myelofibrosis: an international study of 264 patients

scientific article published on 10 May 2012

Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia

scientific article published on 01 November 2004

Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders.

scientific article published on 03 April 2008

Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up

scientific article published on 01 November 2006

Long-term follow-up of young patients with essential thrombocythemia treated with pipobroman

scientific article

Long-term outcomes of 107 patients with myelofibrosis receiving JAK1/JAK2 inhibitor ruxolitinib: survival advantage in comparison to matched historical controls

scientific article

Looking for CALR mutations in familial myeloproliferative neoplasms.

scientific article published on 20 January 2014

Looking for familial nodular lymphocyte-predominant Hodgkin lymphoma.

scientific article published on 3 July 2013

Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis

scientific article published on 19 August 2009

Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations

scientific article published on 11 January 2011

Molecular detection, epidemiology, and genetic characterization of novel European field isolates of equine infectious anemia virus.

scientific article published on 17 November 2010

Molecular remission after allo-SCT in a patient with post-essential thrombocythemia myelofibrosis carrying the MPL (W515A) mutation

scientific article published on 07 September 2009

Muco-cutaneous changes during long-term therapy with hydroxyurea in chronic myeloid leukaemia.

scientific article

Mutational status of myeloproliferative neoplasms.

scientific article published on January 2010

Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis history.

scientific article

Myelofibrotic transformation in essential thrombocythemia. Author reply.

scientific article published on 30 January 2009

Myeloproliferative neoplasms: From JAK2 mutations discovery to JAK2 inhibitor therapies ⬇️

scientific article published on June 1, 2011

New and old prognostic factors in polycythemia vera

scientific article published in January 2009

New generation small-molecule inhibitors in myeloproliferative neoplasms.

scientific article

New molecular genetics in the diagnosis and treatment of myeloproliferative neoplasms.

scientific article published on 25 January 2016

New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment

scientific article published on 06 November 2008

New uses for brentuximab vedotin and novel antibody drug conjugates in lymphoma

scientific article

Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease dissemination

scientific article published on 01 March 2006

Not just clonal expansion of hematopoietic cells, but also activation of their progeny in the pathogenesis of myeloproliferative disorders

scientific article published on 01 February 2006

Novel agents in indolent lymphomas.

scientific article

PDGFRB disease: right diagnosis to prolong survival

scientific article

PRV-1 and its correlation with treatments and disease status in 210 patients with polycythemia vera and essential thrombocythemia

scientific article published on 01 May 2005

Patterns of presentation and thrombosis outcome in patients with polycythemia vera strictly defined by WHO-criteria and stratified by calendar period of diagnosis

scientific article published on 27 February 2015

Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet.

scientific article published on 04 January 2011

Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosis.

scientific article published in March 2002

Pityriasis rosea-like eruption during treatment with imatinib mesylate: description of 3 cases

scientific article

Platelet count predicts driver mutations' co-occurrence in low JAK2 mutated essential thrombocythemia and myelofibrosis

scientific article published on 13 October 2020

Platelet size distinguishes between inherited macrothrombocytopenias and immune thrombocytopenia.

scientific article

Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia.

scientific article

Pomalidomide is active in the treatment of anemia associated with myelofibrosis

scientific article

Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia

scientific article published on 27 November 2015

Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT.

scientific article published on 27 October 2006

Primary leptomeningeal CNS lymphoma presenting as bilateral facial nerve palsy

scientific article published on 24 June 2014

Primary nodal marginal zone B-cell lymphoma: clinical features and prognostic assessment of a rare disease.

scientific article published in January 2007

Prognostic Factors and Models in Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis ⬇️

scientific article published on April 29, 2011

Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.

scientific article published on 26 September 2005

Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients.

scientific article published on 11 September 2008

Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patients.

scientific article

Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and Treatment

scientific article published on 30 August 2007

Pulmonary rhodococcosis in a cat

scientific article published on 26 January 2011

RBC-transfusion guidelines update

scientific article published on 14 February 2012

Red blood cell transfusion-dependency implies a poor survival in primary myelofibrosis irrespective of IPSS and DIPSS ⬇️

scientific article published on September 30, 2010

Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders.

scientific article

Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference.

scientific article published on 10 March 2009

Revised response criteria for polycythemia vera and essential thrombocythemia: an ELN and IWG-MRT consensus project.

scientific article published on 16 April 2013

Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients ⬇️

scientific article published on April 13, 2011

Risk of second cancer in nongastric marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue: a population-based study from northern Italy

scientific article published on 01 January 2007

Role of the molecular staging and response in the management of follicular lymphoma patients

scientific article published on 01 June 2006

Ruxolitinib and survival improvement in patients with myelofibrosis.

scientific article published on 24 September 2014

Ruxolitinib for essential thrombocythemia refractory to or intolerant of hydroxyurea: long-term phase 2 study results

scientific article published on 21 August 2017

Ruxolitinib versus best available therapy in patients with polycythemia vera: 80-week follow-up from the RESPONSE trial.

scientific article published on 21 April 2016

Ruxolitinib versus standard therapy for the treatment of polycythemia vera.

scientific article

Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients

scientific article published on 07 June 2019

Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders

scientific article published on 5 November 2007

Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles

scientific article published on January 2004

Splenic marginal zone lymphoma: Clinical clustering of immunoglobulin heavy chain repertoires

scientific article published on 27 February 2009

Stem cell transplant in MF: it's time to personalize

scientific article published on 01 May 2019

Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT.

scientific article published on 25 October 2009

Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study.

scientific article published on 11 July 2011

Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study ⬇️

scientific article published on June 6, 2013

Survival in young patients with intermediate- / high-risk myelofibrosis: estimates derived from databases for non transplant patients

scientific article published on 01 March 2009

Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease.

scientific article published on 23 November 2015

The 'GGCC' haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia vera

scientific article

The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): international prospective validation and reliability trial in 402 patients

scientific article published on 2 May 2011

The role of sexuality symptoms in myeloproliferative neoplasm symptom burden and quality of life: An analysis by the MPN QOL International Study Group

scientific article published on 12 April 2016

The role of the JAK2 GGCC haplotype and the TET2 gene in familial myeloproliferative neoplasms ⬇️

scientific article published on December 20, 2010

Three-year efficacy, safety, and survival findings from COMFORT-II, a phase 3 study comparing ruxolitinib with best available therapy for myelofibrosis

scientific article

Treatment of early-stage Hodgkin's disease with four cycles of ABVD followed by adjuvant radio-therapy: analysis of efficacy and long-term toxicity

scientific article published on 01 October 2000

Treatment of polycythemia vera and essential thrombocythemia: the role of pipobroman

scientific article (publication date: September 2003)

Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: a collaborative study of 1027 patients

scientific article published on 16 May 2014

Unbiased pro-thrombotic features at diagnosis in 977 thrombocythemic patients with Philadelphia-negative chronic myeloproliferative neoplasms

scientific article published on 07 April 2016

Use of the Functional Assessment of Cancer Therapy--anemia in persons with myeloproliferative neoplasm-associated myelofibrosis and anemia

scientific article published on 14 March 2014

Validation of cytogenetic-based risk stratification in primary myelofibrosis.

scientific article published in April 2010

Validation of follicular lymphoma international prognostic index 2 (FLIPI2) score in an independent series of follicular lymphoma patients

scientific article published on 11 January 2010

What are RBC-transfusion-dependence and -independence?

scientific article published on 07 August 2010

Paulina is supported by:

About Paulina

Help